TGFB1 and prostate carcinoma: According to Wu et al., suppression of TGF-β by silibinin inhibits the differentiation of fibroblasts into CAF, suppresses the expression of vimentin and α-SMA, and thus, decreases the invasiveness of prostate cancer [35].